Naman Jain1, Atena Akbari1, Markus Barth1,2, and Kai-Hsiang Chuang1,3
1Centre for Advanced Imaging, The University of Queensland, Brisbane, Australia, 2School of Information Technology and Electrical Engineering, The University of Queensland, Brisbane, Australia, 3Queensland Brain Institute, The University of Queensland, Brisbane, Australia
Synopsis
Cerebral
Blood Volume (CBV) – weighted vascular-space-occupancy (VASO) functional MRI
(fMRI) has shown superior spatial specificity compared to the conventional
gradient-echo blood-oxygen-level-dependent (BOLD) contrast in humans [1]. Although VASO fMRI has been used for CBV imaging in
rats and monkeys, the applicability of this method in the mouse brain has not
been investigated due to the technical challenges. In this study we examine the
feasibility of VASO fMRI of the visual cortex in the anesthetized mouse.
Introduction
Blood-oxygen-level-dependent
(BOLD) contrast is sensitive to the oxygenation change in blood vessels [2]. However,
the spatial specificity of this contrast is poor as the largest BOLD signal
changes are found in large intracortical and pial veins remote from the site of
neural events [3], making
the interpretation of the BOLD signal challenging. Cerebral blood volume (CBV)
imaging using vascular-space-occupancy (VASO) has shown higher spatial
specificity compared to conventional gradient-echo BOLD signal [1] and has
been used in both human [4] and animal
studies (i.e. cat [5], rat [6], monkey [7]). Using
the transgenic mouse models have proved to be of great significance to understand
neurophysiology and pathological mechanisms of diseases such as Alzheimer’s
Disease [8], [9]. However,
VASO fMRI has not been performed in the mouse brain due to the technical and
experimental challenges such as small brain volume, low SNR and fast arterial
transit times in the mouse brain. In this work, we investigated the feasibility
of CBV imaging in the primary visual cortex (V1) of the mouse brain using VASO.Methods
- Experimental Setup
and Animal Preparation:
This study
was approved by the institutional animal ethics committee. Imaging of six C57BL6 mice
was performed on a 9.4T preclinical MRI (Bruker Biospec, Ettlingen, Germany) with
86mm volume coil for transmit and custom-made 10mm surface coil for receive. Mice
were sedated under 0.2% isoflurane and medetomidine (0.1mg/kg/h, ip) with
temperature, SpO2 and respiration monitored and controlled. Each animal was
scanned for at least 2 sessions to evaluate reproducibility. - BOLD:
Two runs of
BOLD fMRI were acquired using a multi-band EPI sequence with TR/TE= 300/15 ms
and 0.3×0.3×0.5 mm3 resolution [10]. A
flashing blue light with the frequency of 5 Hz was used as the visual
stimulation in 16 blocks, with a 12 s OFF and 3 s ON duration. The AEDES
toolbox (by The University of Eastern Finland, Kuopio, Finland) was used to obtain
BOLD activation maps to localize the activated area of the brain to plan the
VASO acquisition during the experiment and for comparison with the VASO
activation maps later in the analysis. All voxels corresponding to an
uncorrected significance level of p<0.05 were assumed as the activated regions.
- VASO:
A VASO sequence based on modified FAIR pulse sequence
was used for selective inversion (slab width = 16 mm) with TR/TE/TI =
3000/5.02/950 ms, 0.3×0.3×1 mm3 resolution and 6 slices. Blood nulling time (TI) was calculated based
on the reported blood T1 value of the mouse brain (T1 = 2449ms) at 9.4T [11]. We performed a
series of pilot scans to optimize inversion pulse and inversion time that
resulted in the use of a slightly shorter TI (of 950ms). Four runs of
functional images with visual stimulus of different duration (12 blocks of 30
second on and off) were acquired. Structural images were obtained using T2_TurboRARE
sequence as the anatomical reference. Data were analyzed using SPM12 (UCL, UK)
with motion correction but no spatial smoothing. All voxels with t-values above 3.0 corresponding to an uncorrected significance
level of p<0.001 were assumed as the activated regions.
Result
VASO
activation maps of two mice are shown in Figure 1. The averaged VASO signal
time course over 12 blocks and 4 runs per session (Figure 2) demonstrates an expected
negative signal change. 3 mice got a successful VASO response with a signal change of -0.139% (Mouse 1), -0.132% (Mouse 2) and -0.123% (Mouse 3).Discussion
In these
initial results we show that VASO activation areas are more confined to grey
matter compared to BOLD in agreement with previous studies [12], [13]. Our
results show the feasibility of functional VASO imaging in anesthetized mouse
brain at 9.4T. The biggest challenge with VASO is the low sensitivity, which
requires long scan time for data averaging. Potentially, the sensitivity could
be improved by optimizing the inversion slab accounting for the fast arterial
transit times in mouse and using a more sensitive RF coil (cryoprobe).Acknowledgements
The authors acknowledge funding by NHMRC-NIH BRAIN
Initiative Collaborative Research Grant APP1117020, NIH grant R01MH111419. References
[1] H. Lu, X.
Golay, J. J. Pekar, and P. C. M. Van Zijl, “Functional magnetic resonance
imaging based on changes in vascular space occupancy,” Magn. Reson. Med.,
vol. 50, no. 2, pp. 263–274, 2003, doi: 10.1002/mrm.10519.
[2] S. Ogawa, T. ‐M
Lee, A. S. Nayak, and P. Glynn, “Oxygenation‐sensitive contrast in magnetic
resonance image of rodent brain at high magnetic fields,” Magn. Reson. Med.,
vol. 14, no. 1, pp. 68–78, 1990, doi: 10.1002/mrm.1910140108.
[3] K. Uludaǧ, B.
Müller-Bierl, and K. Uǧurbil, “An integrative model for neuronal
activity-induced signal changes for gradient and spin echo functional imaging,”
Neuroimage, vol. 48, no. 1, pp. 150–165, 2009, doi:
10.1016/j.neuroimage.2009.05.051.
[4] L. Huber,
“Mapping human brain activity by functional magnetic resonance imaging of blood
volume,” vol. D, no. November 1985, pp. 1–277, 2015, [Online]. Available:
http://nbn-resolving.de/urn:nbn:de:bsz:15-qucosa-165252.
[5] T. Jin and S.
G. Kim, “Improved cortical-layer specificity of vascular space occupancy fMRI
with slab inversion relative to spin-echo BOLD at 9.4 T,” Neuroimage,
vol. 40, no. 1, pp. 59–67, 2008, doi: 10.1016/j.neuroimage.2007.11.045.
[6] L. R. Huber et
al., “Validating layer-specific VASO across species,” pp. 1–17, 2020, doi:
10.1101/2020.07.24.219378.
[7] L. Huber et
al., “Investigation of the neurovascular coupling in positive and negative
BOLD responses in human brain at 7T,” Neuroimage, vol. 97, pp. 349–362,
2014, doi: 10.1016/j.neuroimage.2014.04.022.
[8] A. Niranjan, I.
N. Christie, S. G. Solomon, J. A. Wells, and M. F. Lythgoe, “fMRI mapping of
the visual system in the mouse brain with interleaved snapshot GE-EPI,” Neuroimage,
vol. 139, pp. 337–345, 2016, doi: 10.1016/j.neuroimage.2016.06.015.
[9] J. Grandjean et
al., “Common functional networks in the mouse brain revealed by
multi-centre resting-state fMRI analysis,” Neuroimage, vol. 205, no.
October 2019, 2020, doi: 10.1016/j.neuroimage.2019.116278.
[10] H. L. Lee, Z.
Li, E. J. Coulson, and K. H. Chuang, “Ultrafast fMRI of the rodent brain using
simultaneous multi-slice EPI,” Neuroimage, vol. 195, no. March, pp.
48–58, 2019, doi: 10.1016/j.neuroimage.2019.03.045.
[11] M. C. Dobre, K.
Uǧurbil, and M. Marjanska, “Determination of blood longitudinal relaxation time
(T1) at high magnetic field strengths,” Magn. Reson. Imaging, vol. 25,
no. 5, pp. 733–735, 2007, doi: 10.1016/j.mri.2006.10.020.
[12] T. Jin and S. G.
Kim, “Spatial dependence of CBV-fMRI: A comparison between VASO and contrast
agent based methods,” Annu. Int. Conf. IEEE Eng. Med. Biol. - Proc., no.
10, pp. 25–28, 2006, doi: 10.1109/IEMBS.2006.259553.
[13] L. Huber et
al., “Slab-selective, BOLD-corrected VASO at 7 tesla provides measures of
cerebral blood volume reactivity with high signal-to-noise ratio,” Magn.
Reson. Med., vol. 72, no. 1, pp. 137–148, 2014, doi: 10.1002/mrm.24916.